CorWave completes enrollment in heart pump feasibility study

• CorWave completed enrollment in its left ventricular assist system feasibility study on October 22, 2026, ahead of a planned pivotal study.
• First clinical data showed automatic support adjustments during activity, with the pump synchronizing to the native heartbeat.
• The feasibility study evaluated safety and performance in advanced heart failure patients at centers in Sydney and Astana.
• Clinical results will be presented at an upcoming international scientific meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sofinnova Partners SAS published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.